Navigation Links
Pepex™ Awarded Qualifying Therapeutic Discovery Project Grant
Date:12/21/2010

ST. LOUIS, Dec. 21, 2010 /PRNewswire/ -- Today, Pepex Biomedical, Inc. announced that the company has been awarded a grant of $244,479.25 under the Qualifying Therapeutic Discovery Project created by Congress as a component of the Patient Protection and Affordable Care Act of 2010, the major health care reform bill, signed into law by President Obama on March 23, 2010.  Pepex submitted their ground-breaking, patented, electrochemical biosensor, nanotechnology and the company received the maximum allowable grant amount.  The Pepex technology can be used in a wide array of products for more rapid diagnosis and intervention of disease which will improve patient quality-of-life and save lives.

Pepex CEO, Steve Collins said, "We are delighted to receive the grant.  These funds were awarded to a select group of companies and this represents another confirmation of Pepex' potential as a valuable contributor to the medical community, for improved patient care."

The Qualifying Therapeutic Discovery Project (QTDP) offers, at the discretion of each recipient company, either a tax credit or grant equal to eligible costs and expenses for tax years 2009 and 2010. Each grant cannot exceed $244,479.25.  The objective of the QTDP was to assist small, innovative biomedical companies with the ultimate goal of reducing long-term, healthcare costs in the United States.

The QTDP defined clear and strict submission qualifications to drive successful attainment of its goal. Only companies with less than 250 employees could submit project applications for grant consideration.  The winning group of recipients has an average number of 20 employees.  Projects submitted were required to demonstrate reasonable potential to result in new therapies for treatment of unmet medical needs in the areas of prevention and detection of chronic or acute disease.  Additional selection criteria for the awards included the likelihood for a project to create high-quality, high-paying jobs in the U.S. market and to increase U.S. competitiveness in the life science and pharmaceutical fields.  Companies were required to submit discrete applications for each project in development to the Department of Treasury.

Pepex is a privately held a medical device company specializing in the development, manufacturing, and marketing of disposable, miniaturized electrochemical biosensors.  The company protects its market opportunities with 64 patents which encompass a broad spectrum from sensor chemistry and architecture, to wireless communications for the sensors, to laser welding and high-speed manufacturing processes.  Pepex' biosensors are the heart of a pipeline of life altering products for medical diagnostics and intervention.  The company is led by a team of business and scientific professionals experienced in the biomedical field and populated by a development staff with a successful track record of delivering next generation biomedical devices to market.  For more information, please visit www.pepex.com.

If you'd like more information about this topic, or to schedule an interview with Steve Collins, please call Andrea Skov at 408.888.3338 or e-mail Andrea at andrea.skov@pepex.com


'/>"/>
SOURCE Pepex Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Market Study Gives Thumbs Up for Pepex™ Trio™ One-Click™ Blood Glucose Meter
2. Pepex™ Unveils Development of First All-In-One Blood Glucose Meter
3. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
4. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
5. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
6. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
7. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
8. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
9. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
10. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
11. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after thirteen ... in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl appearances ... yards by a quarterback (6,109) and the most rushing yards by a quarterback in ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Sean Fay ... Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold ... any other marketer in the last 25 years. , Now, due to changes in ...
Breaking Medicine News(10 mins):